Identification of protein-coding and non-coding RNA expression profiles in CD34+ and in stromal cells in refractory anemia with ringed sideroblasts

Abstract Background Myelodysplastic syndromes (MDS) are a group of clonal hematological disorders characterized by ineffective hematopoiesis with morphological evidence of marrow cell dysplasia resulting in peripheral blood cytopenia. Microarray technology has permitted a refined high-throughput mapping of the transcriptional activity in the human genome. Non-coding RNAs (ncRNAs) transcribed from intronic regions of genes are involved in a number of processes related to post-transcriptional control of gene expression, and in the regulation of exon-skipping and intron retention. Characterization of ncRNAs in progenitor cells and stromal cells of MDS patients could be strategic for understanding gene expression regulation in this disease. Methods In this study, gene expression profiles of CD34+ cells of 4 patients with MDS of refractory anemia with ringed sideroblasts (RARS) subgroup and stromal cells of 3 patients with MDS-RARS were compared with healthy individuals using 44 k combined intron-exon oligoarrays, which included probes for exons of protein-coding genes, and for non-coding RNAs transcribed from intronic regions in either the sense or antisense strands. Real-time RT-PCR was performed to confirm the expression levels of selected transcripts. Results In CD34+ cells of MDS-RARS patients, 216 genes were significantly differentially expressed (q-value ≤ 0.01) in comparison to healthy individuals, of which 65 (30%) were non-coding transcripts. In stromal cells of MDS-RARS, 12 genes were significantly differentially expressed (q-value ≤ 0.05) in comparison to healthy individuals, of which 3 (25%) were non-coding transcripts. Conclusions These results demonstrated, for the first time, the differential ncRNA expression profile between MDS-RARS and healthy individuals, in CD34+ cells and stromal cells, suggesting that ncRNAs may play an important role during the development of myelodysplastic syndromes.

Implications of purinergic receptor-mediated intracellular calcium transients in neural differentiation

Purinergic receptors participate, in almost every cell type, in controlling metabolic activities and many physiological functions including signal transmission, proliferation and differentiation. While most of P2Y receptors induce transient elevations of intracellular calcium concentration by activation of intracellular calcium pools and forward these signals as waves which can also be transmitted into neighboring cells, P2X receptors produce calcium spikes which also include activation of voltage-operating calcium channels. P2Y and P2X receptors induce calcium transients that activate transcription factors responsible for the progress of differentiation through mediators including calmodulin and calcineurin. Expression of P2X2 as well as of P2X7 receptors increases in differentiating neurons and glial cells, respectively. Gene expression silencing assays indicate that these receptors are important for the progress of differentiation and neuronal or glial fate determination. Metabotropic receptors, mostly P2Y1 and P2Y2 subtypes, act on embryonic cells or cells at the neural progenitor stage by inducing proliferation as well as by regulation of neural differentiation through NFAT translocation. The scope of this review is to discuss the roles of purinergic receptor-induced calcium spike and wave activity and its codification in neurodevelopmental and neurodifferentiation processes.

Identificação do nicho de progenitores mesenquimais no fígado de embriões e fetos caninos: uma fonte de células-tronco para terapia celular

As células-tronco (CT) derivadas dos tecidos fetais (TF) foram as mais recentes descobertas entre as CT, e ultimamente tem demonstrado amplo potencial terapêutico, dentre os TF o fígado fetal (FF) apresenta grande potencial terapêutico. Este órgão durante o período fetal em mamíferos é um nicho hematopoético transitório, sendo o principal órgão responsável pela hematopoese no feto, além de contribuir com a formação do nicho definitivo na medula óssea adulta, portanto pode ser considerado um nicho de células-tronco mesenquimais (CTM) e progenitores. No entanto, pouco se sabe sobre a localização destas células no FF, desta forma o presente estudo visa identificar o nicho de CTM e progenitores em FF de cães, a fim de contribuir com as técnicas de isolamento e extração celular. Em conjunto foi realizada a verificação da expressão do fator de transcrição Oct-3/4 e da proteína delta polimerase do DNA (PCNA). Para a análise foram utilizados cinco embriões e 11 fetos caninos com idades gestacionais variando de 25-60 dias. Os resultados elucidaram a partir de 25 dias de gestação o FF apresentou-se volumoso e composto por todas as estruturas típicas, dentre elas a tríade portal, ductos biliares e ramos das artérias hepáticas. Com 30 dias de gestação foram identificados os primeiros sitos de progenitores mesenquimais (PM) enquanto que aos 60 dias os nichos estavam completamente formados com localização semelhante ao fígado adulto (FA). No entanto, células imunopositivas para Oct-3/4 não foram identificadas; sendo assim, destacamos que o FF é uma fonte de PM, apresentando-se como uma alternativa para a utilização terapêutica, bem como para os estudos da biologia do desenvolvimento das CTM e progenitores.

In search of mechanisms associated with mesenchymal stem cell-based therapies for acute kidney injury

Acute kidney injury (AKI) is classically described as a rapid loss of kidney function. AKI affects more than 15% of all hospital admissions and is associated with elevated mortality rates. Although many advances have occurred, intermittent or continuous renal replacement therapies are still considered the best options for reversing mild and severe AKI syndrome. For this reason, it is essential that innovative and effective therapies, without side effects and complications, be developed to treat AKI and the end-stages of renal disease. Mesenchymal stem cell (MSC) based therapies have numerous advantages in helping to repair inflamed and damaged tissues and are being considered as a new alternative for treating kidney injuries. Numerous experimental models have shown that MSCs can act via differentiation-independent mechanisms to help renal recovery. Essentially, MSCs can secrete a pool of cytokines, growth factors and chemokines, express enzymes, interact via cell-to-cell contacts and release bioagents such as microvesicles to orchestrate renal protection. In this review, we propose seven distinct properties of MSCs which explain how renoprotection may be conferred: 1) anti-inflammatory; 2) pro-angiogenic; 3) stimulation of endogenous progenitor cells; 4) anti-apoptotic; 5) anti-fibrotic; 6) anti-oxidant; and 7) promotion of cellular reprogramming. In this context, these mechanisms, either individually or synergically, could induce renal protection and functional recovery. This review summarises the most important effects and benefits associated with MSC-based therapies in experimental renal disease models and attempts to clarify the mechanisms behind the MSC-related renoprotection. MSCs may prove to be an effective, innovative and affordable treatment for moderate and severe AKI. However, more studies need to be performed to provide a more comprehensive global understanding of MSC-related therapies and to ensure their safety for future clinical applications.

Diabete ed ischemia critica degli arti inferiori. Studio del danno della parete arteriosa e del ruolo dell'endotelio circolante nella riparazione tessutale e nella neoangiogenesi

Objectives In diabetic and non diabetic patients with peripheral artery obstructive disease (PAOD), we sought to establish whether the vascular wall damage, the mature circulating endothelium and the "in situ" neoangiogenesis are related with each other. Design In the peripheral blood of diabetic patients suffering critical ischaemia associated with peripheral artery disease, low levels and poor function of circulating endothelial progenitor cells (EPCs) were observed. Moreover, circulating endothelial cells (CECs) have been described in different conditions of vascular injury. In this type of disorders, which are all characterized by endothelial damage, neoangiogenesis plays a key role. Materials In the study we recruited 22 diabetic and 16 non diabetic patients, all of them suffering PAOD and critical ischaemia; healthy subjects and multiorgan donors have also been considered like controls. Methods Histopathologic characterization was performed on arterial tissue samples under a light microscope. Flow cytofluorimetric analysis was used to quantify CECs in peripheral blood samples. "In situ" expression of the Vascular Endothelial Growth Factor (VEGF) and Metalloproteinase 9 (MMP-9) transcripts was quantified in a Real Time-PCR analysis. Circulating VEGF concentration was determined by an ELISA assay. Results Arterial wall from diabetic patients, compared with non diabetic subjects, revealed a higher incidence of serious lesions (60% vs 47%) and a lower number of capillaries (65% vs 87%). Mean number of CECs/ml was significantly increased in all patients, compared to healthy controls (p=0.001). Compared to healthy subjects, VEGF transcripts expression resulted significantly higher in diabetic patients and in all patients (p<0.05) and a similar result was obtained in the MMP-9 transcripts expression. Serum VEGF concentration was significantly increased in PAOD patients correlated with controls (p=0.0431). Conclusions Our study demonstrates that in all patients considered, probably, regressive phenomenons prevail on reparative ones, causing an inesorable and progressive degeneration of the vascular wall, worse by diabetes. The vascular damage can be monitored by determining CECs number and its severity and development are emphasized by the MMP-9 transcripts expression. The "in situ" VEGF increased expression seems to be the evidence of a parietal cells bid to induce local angiogenesis. This reparing mechanism could induce the EPCs mobilitation by means the release of VEGF from the arterial wall. The mechanism, however, is ineffective like demonstrated by the EPCs reduced number and activities observed in patients suffering PAOD and critical ischaemia.

Rag2-/-;gammac-/- immunodeficient mice, a new preclinical model to study antitumor approaches

Animal models have been relevant to study the molecular mechanisms of cancer and to develop new antitumor agents. Anyway, the huge divergence in mouse and human evolution made difficult the translation of the gained achievements in preclinical mouse based studies. The generation of clinically relevant murine models requires their humanization both concerning the creation of transgenic models and the generation of humanized mice in which to engraft a functional human immune system, and reproduce the physiological effects and molecular mechanisms of growth and metastasization of human tumors. In particular, the availability of genotypically stable immunodepressed mice able to accept tumor injection and allow human tumor growth and metastasization would be important to develop anti-tumor and anti-metastatic strategies. Recently, Rag2-/-;gammac-/- mice, double knockout for genes involved in lymphocyte differentiation, had been developed (CIEA, Central Institute for Experimental Animals, Kawasaki, Japan). Studies of human sarcoma metastasization in Rag2-/-; gammac-/- mice (lacking B, T and NK functionality) revealed their high metastatic efficiency and allowed the expression of human metastatic phenotypes not detectable in the conventionally used nude murine model. In vitro analysis to investigate the molecular mechanisms involved in the specific pattern of human sarcomas metastasization revealed the importance of liver-produced growth and motility factors, in particular the insulin-like growth factors (IGFs). The involvement of this growth factor was then demonstrated in vivo through inhibition of IGF signalling pathway. Due to the high growth and metastatic propensity of tumor cells, Rag2-/-;gammac-/- mice were used as model to investigate the metastatic behavior of rhabdomyosarcoma cells engineered to improve the differentiation. It has been recently shown that this immunodeficient model can be reconstituted with a human immune system through the injection of human cord blood progenitor cells. The work illustrated in this thesis revealed that the injection of different human progenitor cells (CD34+ or CD133+) showed peculiar engraftment and differentiation abilities. Experiments of cell vaccination were performed to investigate the functionality of the engrafted human immune system and the induction of specific human immune responses. Results from such experiments will allow to collect informations about human immune responses activated during cell vaccination and to define the best reconstitution and experimental conditions to create a humanized model in which to study, in a preclinical setting, immunological antitumor strategies.

Alterazioni dell'immunità umorale nei pazienti con sarcoma di Kaposi classico: caratterizzazione dei linfociti B circolanti e delle loro sottopopolazioni

Objectives: Human Herpesvirus 8 (HHV-8) is the etiological agent of Kaposi’s Sarcoma (KS) and it is also associated with two B cell lymphoproliferative diseases: primary effusion lymphoma (PEL), and the plasmablastic form of multicentric Castelman’s disease (MCD). HHV-8 establishes persistent infection in the host with tropism for multiple cell types. In KS patients, the virus is found in tumor-spindle cells, peripheral blood monocytes, endothelial progenitor circulating cells, T and B lymphocytes. Peripheral B cells represent one of the major virus reservoir, but the consequences of HHV-8 infection of these cells have been poorly characterized. Therefore, in this study the frequency, the immunophenotypic profile and the functional activity of different peripheral B cell subsets in patients with classic KS (cKS) was analysed in order to identify potential alterations of these cells. The classic variant of KS is ideal to perform such studies, as it lacks confounding factors such as HIV or EBV infection and immunosuppression. Methods: Whole-blood samples from patients with the classical form of KS (cKS) (n=62) and healthy age and sex-matched seronegative controls (HSN) (n=43) were analyzed by multiparametric flow-cytometry to determine the frequency of B cells and their subpopulations, as well as their surface expression of immunoglobulins and activation markers. Results: The frequency of circulating B cells was significantly higher in cKS patients than in controls. In particular, the analysis of the B cell subsets revealed a higher frequency of naïve B cells (CD19+CD27-), among which transitional CD19+CD38highCD5+ and pre-naïve (CD27-CD38intCD5+ ) B cells demonstrated an expansion. Memory B cells (CD19+CD27+) did not differ between the two study groups, except from a higher frequency of CD19+CD27+IgM+IgD+ B cells, the typical phenotype of marginal zone (MZ) B cells, in cKS patients. The characterization of membrane surface activation markers showed lower levels of the activation marker HLA-DR only on CD27- B cells, while CD80 and CD86 were less represented in all the the B cells from cKS patients. Moreover, B cells from cKS patients were smaller and with less granules than the ones from controls. Conclusion: Taken together, these results clearly indicate that circulating B cells are altered in patients with cKS, showing an expansion of the immature phenotypes. These B cell alterations may be due to an indirect viral effect rather than to a direct one: the cytokines expressed in the microenvironment typical of cKS may cause a faster release of immature cells from the bone marrow and a lower grade of peripheral differentiation, as already suggested for other chronic viral infections such as HIV and HCV. Further studies will be necessary to understand how these alterations contribute to the pathogenesis of KS and, eventually, to the different clinical evolution of the disease.

Astrophysikalische Bedingungen für einen r-Prozess im Hoch-Entropie-Wind von Typ II Supernovae

Sterne mit einer Anfangsmasse zwischen etwa 8 und 25 Sonnenmassen enden ihre Existenz mit einer gewaltigen Explosion, einer Typ II Supernova. Die hierbei entstehende Hoch-Entropie-Blase ist ein Bereich am Rande des sich bildenden Neutronensterns und gilt als möglicher Ort für den r-Prozess. Wegen der hohen Temperatur T innerhalb der Blase ist die Materie dort vollkommen photodesintegriert. Das Verhältnis von Neutronen zu Protonen wird durch die Elektronenhäufigkeit Ye beschrieben. Die thermodynamische Entwicklung des Systems wird durch die Entropie S gegeben. Da die Expansion der Blase schnell vonstatten geht, kann sie als adiabatisch betrachtet werden. Die Entropie S ist dann proportional zu T^3/rho, wobei rho die Dichte darstellt. Die explizite Zeitentwicklung von T und rho sowie die Prozessdauer hängen von Vexp, der Expansionsgeschwindigkeit der Blase, ab. Der erste Teil dieser Dissertation beschäftigt sich mit dem Prozess der Reaktionen mit geladenen Teilchen, dem alpha-Prozess. Dieser Prozess endet bei Temperaturen von etwa 3 mal 10^9 K, dem sogenannten "alpha-reichen" Freezeout, wobei überwiegend alpha-Teilchen, freie Neutronen sowie ein kleiner Anteil von mittelschweren "Saat"-Kernen im Massenbereich um A=100 gebildet werden. Das Verhältnis von freien Neutronen zu Saatkernen Yn/Yseed ist entscheidend für den möglichen Ablauf eines r-Prozesses. Der zweite Teil dieser Arbeit beschäftigt sich mit dem eigentlichen r-Prozess, der bei Neutronenanzahldichten von bis zu 10^27 Neutronen pro cm^3 stattfindet, und innerhalb von maximal 400 ms sehr neutronenreiche "Progenitor"-Isotope von Elementen bis zum Thorium und Uran bildet. Bei dem sich anschliessendem Ausfrieren der Neutroneneinfangreaktionen bei 10^9 K und 10^20 Neutronen pro cm^3 erfolgt dann der beta-Rückzerfall der ursprünglichen r-Prozesskerne zum Tal der Stabilität. Diese Nicht-Gleichgewichts-Phase wird in der vorliegenden Arbeit in einer Parameterstudie eingehend untersucht. Abschliessend werden astrophysikalische Bedingungen definiert, unter denen die gesamte Verteilung der solaren r-Prozess-Isotopenhäufigkeiten reproduziert werden können.

The role of the NG2 proteoglycan in migration and characterization of the interaction with the intracellular binding partner, Syntenin

NG2 is a transmembrane proteoglycan with two N-terminal LNS domains and a C-terminal PDZ-binding motif. It is expressed in the developing and adult CNS by oligodendroglial precursor cells and subpopulations of perisynaptic glia and elsewhere by many immature cell types. In order to elucidate the functions of the protein and the heterogenous cell population which expresses it, we undertook to identify and characterise interaction partners of the molecule. The presence of the C-terminal PDZ recognition site in NG2 suggested PDZ-domain proteins as intracellular binding partners. In this work, interaction between the PDZ protein Syntenin and NG2 has been characterised. Syntenin is known to be involved in plasma membrane dynamics, metastasis and adhesion. Syntenin may thus link NG2 to the cytoskeleton, mediating migration of developing oligodendrocytes to axonal tracts prior to myelination, as well as process movement of NG2+ perisynaptic glia. NG2 is involved in cell spreading and polyclonal antibodies against NG2 inhibit the migration of immature glia and cell lines expressing the molecule. In this work we have characterised the segments of the extracellular portion of NG2 that are involved in migration. We found that the extracellular region immediately preceding the transmembrane segment is most important for cell motility. As part of this thesis, biochemical approaches to identify a trans-binding ligand interacting with the extracellular part of NG2 was also explored.

Progenitori endoteliali nei pazienti con Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD) in fase uremica: effetti del trattamento con vitamina D.

L'insufficienza renale cronica (CKD) è associata ad un rischio cardiovascolare più elevato rispetto alla popolazione generale: fattori come uremia, stress ossidativo, età dialitica, infiammazione, alterazioni del metabolismo minerale e presenza di calcificazioni vascolari incidono fortemente sulla morbosità e mortalità per cause cardiovascolari nel paziente uremico. Diversi studi hanno verificato il coinvolgimento dei progenitori endoteliali (EPC) nella malattia aterosclerotica ed è stato dimostrato che esprimono osteocalcina, marcatore di calcificazione. Inoltre, nella CKD è presente una disfunzione in numero e funzionalità delle EPC. Attualmente, il ruolo delle EPC nella formazione delle calcificazioni vascolari nei pazienti in dialisi non è stato ancora chiarito. Lo scopo della tesi è quello di studiare le EPC prelevate da pazienti con CKD, al fine di determinarne numero e fenotipo. È stato anche valutato l'effetto del trattamento in vitro e in vivo con calcitriolo e paracalcitolo sulle EPC, dato il deficit di vitamina D dei pazienti con CKD: il trattamento con vitamina D sembra avere effetti positivi sul sistema cardiovascolare. Sono stati valutati: numero di EPC circolanti e la relativa espressione di osteocalcina e del recettore della vitamina D; morfologia e fenotipo EPC in vitro; effetti di calcitriolo e paracalcitolo sull’espressione di osteocalcina e sui depositi di calcio. I risultati dello studio suggeriscono che il trattamento con vitamina D abbia un effetto positivo sulle EPC, aumentando il numero di EPC circolanti e normalizzandone la morfologia. Sia calcitriolo che paracalcitolo sono in grado di ridurre notevolmente l’espressione di OC, mentre solo il paracalcitolo ha un effetto significativo sulla riduzione dei depositi di calcio in coltura. In conclusione, il trattamento con vitamina D sembra ridurre il potenziale calcifico delle EPC nell’uremia, aprendo nuove strade per la gestione del rischio cardiovascolare nei pazienti affetti da CKD.

Effect of hypoxia and hyperglycemia on cell bioenergetics

Mitochondria have a central role in energy supply in cells, ROS production and apoptosis and have been implicated in several human disease and mitochondrial dysfunctions in hypoxia have been related with disorders like Type II Diabetes, Alzheimer Disease, inflammation, cancer and ischemia/reperfusion in heart. When oxygen availability becomes limiting in cells, mitochondrial functions are modulated to allow biologic adaptation. Cells exposed to a reduced oxygen concentration readily respond by adaptive mechanisms to maintain the physiological ATP/ADP ratio, essential for their functions and survival. In the beginning, the AMP-activated protein kinase (AMPK) pathway is activated, but the responsiveness to prolonged hypoxia requires the stimulation of hypoxia-inducible factors (HIFs). In this work we report a study of the mitochondrial bioenergetics of primary cells exposed to a prolonged hypoxic period . To shine light on this issue we examined the bioenergetics of fibroblast mitochondria cultured in hypoxic atmospheres (1% O2) for 72 hours. Here we report on the mitochondrial organization in cells and on their contribution to the cellular energy state. Our results indicate that prolonged hypoxia cause a significant reduction of mitochondrial mass and of the quantity of the oxidative phosphorylation complexes. Hypoxia is also responsible to damage mitochondrial complexes as shown after normalization versus citrate synthase activity. HIF-1α plays a pivotal role in wound healing, and its expression in the multistage process of normal wound healing has been well characterized, it is necessary for cell motility, expression of angiogenic growth factor and recruitment of endothelial progenitor cells. We studied hypoxia in the pathological status of diabetes and complications of diabetes and we evaluated the combined effect of hyperglycemia and hypoxia on human dermal fibroblasts (HDFs) and human dermal micro-vascular endothelial cells (HDMECs) that were grown in high glucose, low glucose concentrations and mannitol as control for the osmotic challenge.

Zelluläre Kontrolle adulter Neurogenese - Expression und Funktion des VEGF-Rezeptor-1 (Flt-1) im adulten Säugerhirn

Neurale Stammzellen sind im adulten Säugerhirn in der Subventrikulären Zone (SVZ) der Lateralventrikel und dem Hippokampus lokalisiert. In der SVZ entstandene neurale Zellen migrieren entlang eines von Astrozyten umgebenen Pfades, dem Rostralmigratorischen Strom (RMS), zum Olfaktorischen Bulbus (OB), wo sie zu olfaktorischen Interneuronen differenzieren. Vaskuläre Wachstumsfaktoren, wie VEGF-A beeinflussen die adulte Neurogenese. Die vorliegende Arbeit beschreibt erstmalig detailliert die spezifische Expression des VEGF-Rezeptor-1 (VEGFR-1) in den Regionen olfaktorischer und hippokampaler Neurogenese des adulten ZNS. Die Ergebnisse zeigen, dass VEGFR-1 im adulten Hirn hauptsächlich in GFAP-positiven Zellen in der SVZ, dem RMS, dem OB, dem Corpus callosum und dem Hippokampus exprimiert ist. In vivo-Analysen transgener Mäuse (Flt-1TK-/-), denen die Signaltransduktionsdomäne des VEGFR-1 fehlt, demonstrieren hier erstmals eine Rolle des VEGFR-1 in adulter Neurogenese. Flt-1TK-/- weisen eine erhöhte Proliferation neuronaler Vorläuferzellen der SVZ auf. Im RMS ist jedoch 6 Tage nach BrdU-Administration die Anzahl markierter Zellen im Vergleich zum Wildtyp (wt) um 47,97% reduziert, ohne dass es zu einer Akkumulation in der SVZ kommt. Zusammen mit der in Kulturversuchen stark erhöhten Migrationsgeschwindigkeit von Neuroblasten der Flt-1TK-/- und einer verminderten Abwanderung von Zellen aus dem RMS ins Corpus callosum der Flt-1Tk-/-, weist dies auf eine gesteigerte Migration zum OB hin. Tatsächlich war der OB der Flt-1TK-/-, vor allem die Plexiform- und Periglomerulärzellschicht (PGL), signifikant vergrößert. Im OB der transgenen Tiere migrieren zudem signifikant mehr BrdU-markierte Zellen in die PGL. Dort differenzieren signifikant mehr Neurone als im wt. Subtypisierungen zeigen, zudem eine erhöhte Differenzierung in dopaminerge Interneurone in der PGL der Flt-1TK-/-. Im Gehirn Flt-1TK-/- war die Konzentration von VEGF-A erhöht. Intrazerebroventrikuläre Infusion von VEGF-A in wt-Tiere erbrachte den eindeutigen Nachweis, dass die Erhöhung der VEGF-A-Konzentration im Gehirn der Flt-1TK-/- ursächlich für die in diesen Tieren beobachtete Reduktion der BrdU-positiven Zellen im RMS ist. Dies ist gleichzeitig der erste Nachweis einer Wirkung von VEGF-A auf Neuroblasten im RMS in vivo unter physiologischen Bedingungen. Die erhöhte VEGF-A-Konzentration könnte auch den anderen hier dargelegten Effekten zugrunde liegen. VEGFR-1 ist somit ein regulatorischer Faktor für die adulte olfaktorische Neurogenese und spielt eine potentielle Rolle in der Differenzierung dopaminerger Interneurone.

Mechanismen der Progenitorzell-induzierten Gefäßneubildung und myokardialen Funktionsverbesserung

Entscheidend für die Sauerstoffversorgung im ischämischen Gewebe ist die Bildung von Blutgefäßen. Dieser Vorgang findet im erwachsenen Organismus in Form von Arteriogenese, Angiogenese und Vaskulogenese statt. Die Entdeckung, dass endotheliale Progenitorzellen (EPC) aus dem Knochenmark mobilisiert werden können, um sich im Ischämiegebiet an der Bildung neuer Kapillaren zu beteiligen, eröffnet einen vollkommen neuen therapeutischen Ansatz. In der hier vorliegenden Arbeit konnte in drei unterschiedlichen Tiermodellen, dem Matrigelmodell, dem Hinterlaufischämiemodell und dem Infarktmodell der Nacktmaus gezeigt werden, dass eine Zelltherapie mit EPC die Neovaskularisation steigert und zu einer myokardialen Funktionsverbesserung beiträgt. Der entscheidende Beitrag der Arbeit liegt jedoch in der Erforschung des Zeitraums der Wirkung der Stammzelltherapie. In allen drei Tiermodellen konnte durch ein spezifisches Abtöten der mit der viralen Thymidinkinase (TK) transduzierten EPC der positive Effekt auf die Neovaskularisation gestoppt werden. Im Herzinfarktmodell der Nacktmaus kam es sogar zu einer signifikanten Verschlechterung der Herzfunktion sowie zu einer Vergrößerung des Infarktareals. Dieser Effekt war durch Apoptose der Zellen in der dritten und vierten Woche nach Infarkt und Zellinfusion zu beobachten. Somit besitzen EPC nicht nur eine Rolle in der initialen Freisetzung von Zytokinen, sondern tragen auch langfristig zur Aufrechterhaltung des zelltherapeutischen Effektes bei. Ob hierfür allein der Mechanismus der Differenzierung verantwortlich ist, bleibt in weiteren Untersuchungen abzuklären. Denkbar wäre auch eine Beeinflussung des Remodeling über parakrine Langzeiteffekte. Im zweiten Teil der Doktorarbeit wurde versucht, das eingeschränkte zelltherapeutische Potential von Progenitorzellen von Patienten mit „Koronarer Herzkrankheit“ (KHK) und ischämischer Kardiomyopathie mit Hilfe zweier eNOSTranskriptionsverstärker, „eNOS-enhancer“, zu verbessern. Im Matrigelmodell der Maus konnten wir eine Verbesserung des Neovaskularisationspotentials von Knochenmarkszellen (BMC) von Patienten nach Präinkubation mit dem eNOS-enhancer nachweisen. Auch im Myokardinfarktmodell der Maus konnten eine Verbesserung der Herzfunktion und eine Reduktion der Infarktgröße beobachtet werden. Beim direkten Vergleich der beiden eNOS-enhancer konnte kein Unterschied gefunden werden. Zusammenfassend leistet die hier vorliegende Arbeit einen wichtigen Beitrag zum Verständnis für die Bedeutung von Progenitorzellen im Rahmen der Stammzelltherapie nach Myokardinfarkt. Ferner wurde die Möglichkeit aufgezeigt, durch gezielte Beeinflussung der Progenitorzellen ihr therapeutisches Potential signifikant zu steigern.

Mesenchymal stromal cell: new applications for regenerative medicine

In the last decades mesenchymal stromal cells (MSC), intriguing for their multilineage plasticity and their proliferation activity in vitro, have been intensively studied for innovative therapeutic applications. In the first project, a new method to expand in vitro adipose derived-MSC (ASC) while maintaining their progenitor properties have been investigated. ASC are cultured in the same flask for 28 days in order to allow cell-extracellular matrix and cell-cell interactions and to mimic in vivo niche. ASC cultured with this method (Unpass cells) were compared with ASC cultured under classic condition (Pass cells). Unpass and Pass cells were characterized in terms of clonogenicity, proliferation, stemness gene expression, differentiation in vitro and in vivo and results obtained showed that Unpass cells preserve their stemness and phenotypic properties suggesting a fundamental role of the niche in the maintenance of ASC progenitor features. Our data suggests alternative culture conditions for the expansion of ASC ex vivo which could increase the performance of ASC in regenerative applications. In vivo MSC tracking is essential in order to assess their homing and migration. Super-paramagnetic iron oxide nanoparticles (SPION) have been used to track MSC in vivo due to their biocompatibility and traceability by MRI. In the second project a new generation of magnetic nanoparticles (MNP) used to label MSC were tested. These MNP have been functionalized with hyperbranched poly(epsilon-lysine)dendrons (G3CB) in order to interact with membrane glycocalix of the cells avoiding their internalization and preventing any cytotoxic effects. In literature it is reported that labeling of MSC with SPION takes long time of incubation. In our experiments after 15min of incubation with G3CB-MNP more then 80% of MSC were labeled. The data obtained from cytotoxic, proliferation and differentiation assay showed that labeling does not affect MSC properties suggesting a potential application of G3CB nano-particles in regenerative medicine.

Funktionelle Analyse der Gliazellwanderung im Drosophila-Embryo

Gliazellen kommen in allen höheren Organismen vor und sind sowohl für die korrekte Entwicklung, als auch für die Funktionalität des adulten Nervensystems unerlässlich. Eine der mannigfachen Funktionen dieses Zelltyps ist die Umhüllung von Axonen im zentralen und peripheren Nervensystem (ZNS und PNS). Um eine vollständige Umhüllung zu gewährleisten, wandern Gliazellen während der Neurogenese zum Teil über enorme Distanzen von ihrem Entstehungsort aus. Dies trifft insbesondere auf die Gliazellen zu, durch deren Membranausläufer die distalen Axonbereiche der peripheren Nerven isoliert werden.rnIn dieser Arbeit wurde die Migration von Gliazellen anhand des Modelorganismus Drosophila untersucht. Ein besonderes Interesse galt dabei der Wanderung einer distinkten Population von Gliazellen, den sogenannten embryonalen Peripheren Gliazellen (ePG). Die ePGs werden überwiegend im sich entwickelnden ventralen Bauchmark geboren und wandern anschließend entlang der peripheren Nerventrakte nach dorsal aus, um diese bis zum Ende der Embryogenese zu umhüllen und dadurch die gliale Blut-Nerv-Schranke zu etablieren. Das Hauptziel dieser Arbeit bestand darin, neue Faktoren bzw. Mechanismen aufzudecken, durch welche die Migration der ePGs reguliert wird. Dazu wurde zunächst der wildtypische Verlauf ihrer Wanderung detailliert analysiert. Es stellte sich heraus, dass in jedem abdominalen Hemisegment eine invariante Anzahl von 12 ePGs von distinkten neuralen Vorläuferzellen generiert wird, die individuelle Identitäten besitzen und mittels molekularer Marker auf Einzelzellebene identifiziert werden können. Basierend auf der charakteristischen Lage der Zellen erfolgte die Etablierung einer neuen, konsistenten Nomenklatur für sämtliche ePGs. Darüber hinaus offenbarten in vivo Migrationsanalysen, dass die Wanderung individueller ePGs stereotyp verläuft und demzufolge weitestgehend prädeterminiert ist. Die genaue Kenntnis der wildtypischen ePG Migration auf Einzelzellebene diente anschließend als Grundlage für detaillierte Mutantenanalysen. Anhand derer konnte für den ebenfalls als molekularen Marker verwendeten Transkriptionsfaktor Castor eine Funktion als zellspezifische Determinante für die korrekte Spezifizierung der ePG6 und ePG8 nachgewiesen werden, dessen Verlust in einem signifikanten Migrationsdefekt dieser beiden ePGs resultiert. Des Weiteren konnte mit Netrin (NetB) der erste diffusible und richtungsweisende Faktor für die Migration von ePGs enthüllt werden, der in Interaktion mit dem Rezeptor Uncoordinated5 speziell die Wanderung der ePG6 und ePG8 leitet. Die von den übrigen Gliazellen unabhängige Navigation der ePG6 und ePG8 belegt, dass zumindest die Migration von Gruppen der ePGs durch unterschiedliche Mechanismen kontrolliert wird, was durch die Resultate der durchgeführten Ablationsexperimente bestätigt wird. rnFerner konnte gezeigt werden, dass während der frühen Gliogenese eine zuvor unbekannte, von Neuroblasten bereitgestellte Netrinquelle an der initialen Wegfindung der Longitudinalen Gliazellen (eine Population Neuropil-assoziierter Gliazellen im ZNS) beteiligt ist. In diesem Kontext erfolgt die Signaldetektion bereits in deren Vorläuferzelle, dem Longitudinalen Glioblasten, zellautonom über den Rezeptor Frazzled. rnFür künftige Mutantenscreens zur Identifizierung weiterer an der Migration der ePGs beteiligter Faktoren stellt die in dieser Arbeit präsentierte detaillierte Beschreibung eine wichtige Grundlage dar. Speziell in Kombination mit den vorgestellten molekularen Markern liefert sie die Voraussetzung dafür, individuelle ePGs auch im mutanten Hintergrund zu erfassen, wodurch selbst subtile Phänotypen überhaupt erst detektiert und auf Einzelzellebene analysiert werden können. Aufgrund der aufgezeigten voneinander unabhängigen Wegfindung, erscheinen Mutantenanalysen ohne derartige Möglichkeiten wenig erfolgversprechend, da Mutationen vermutlich mehrheitlich die Migration einzelner oder weniger ePGs beeinträchtigen. Letzten Endes wird somit die Aussicht verbessert, weitere neuartige Migrationsfaktoren im Modellorganismus Drosophila zu entschlüsseln, die gegebenenfalls bis hin zu höheren Organismen konserviert sind und folglich zum Verständnis der Gliazellwanderung in Vertebraten beitragen.